Patents by Inventor Tsai-Wei Hsu
Tsai-Wei Hsu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11923396Abstract: An integrated circuit includes a photodetector. The photodetector includes one or more dielectric structures positioned in a trench in a semiconductor substrate. The photodetector includes a photosensitive material positioned in the trench and covering the one or more dielectric structures. A dielectric layer covers the photosensitive material. The photosensitive material has an index of refraction that is greater than the indices of refraction of the dielectric structures and the dielectric layer.Type: GrantFiled: April 18, 2022Date of Patent: March 5, 2024Assignee: Taiwan Semiconductor Manufacturing Co., Ltd.Inventors: Chun-Wei Hsu, Tsai-Hao Hung, Chung-Yu Lin, Ying-Hsun Chen
-
Patent number: 10101340Abstract: Described is a method of detecting a protein fragment in a urine sample and a serum sample. The protein fragment is a urine precursor alpha-2-HS-glycoprotein, urine alpha-1 antitrypsin, urine alpha-1 acid glycoprotein, urine osteopontin, or serum osteopontin fragment. The urine sample and the serum sample are obtained from the same individual.Type: GrantFiled: May 24, 2013Date of Patent: October 16, 2018Assignee: Bio Preventive Medicine Corp.Inventors: Wei-Ya Lin, Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ping-Fu Cheng, Tsai-Wei Hsu, Hung-Yi Li, Yi-Ting Chen, Yuh-Feng Ling, Jin-Shuen Chen, Yen-Peng Li
-
Patent number: 9442120Abstract: Use of urine biomarkers for diagnosing nephropathy, monitoring nephropathy progress, and assessing efficacy of a nephropathy treatment. These urine biomarkers include leukocyte-associated Ig-like receptor-2, alpha-1 acid glycoprotein, their fragments, and combinations thereof.Type: GrantFiled: June 7, 2013Date of Patent: September 13, 2016Assignee: Industrial Technology Research InstituteInventors: Tzu-Ling Tseng, Ching-Fang Lu, Wei-Ya Lin, Tsai-Wei Hsu, Mary Ya-Ping Yeh, Yi-Ting Chen, Chwei-Shiun Yang
-
Publication number: 20130266976Abstract: Use of urine biomarkers for diagnosing nephropathy, monitoring nephropathy progress, and assessing efficacy of a nephropathy treatment. These urine biomarkers include leukocyte-associated Ig-like receptor-2, alpha-1 acid glycoprotein, their fragments, and combinations thereof.Type: ApplicationFiled: June 7, 2013Publication date: October 10, 2013Inventors: Tzu-Ling Tseng, Ching-Fang Lu, Wei-Ya Lin, Tsai-Wei Hsu, Mary Ya-Ping Yeh, Yi-Ting Chen, Chwei-Shiun Yang
-
Publication number: 20130252267Abstract: Described are uses of urine and serum biomarkers in diagnosing diabetic nephropathy, staging diabetic nephropathy, monitoring diabetic nephropathy progress, and assessing efficacy of diabetic nephropathy treatments. These biomarkers include urine precursor alpha-2-HS-glycoprotein, urine alpha-1 antitrypsin, urine alpha-1 acid glycoprotein, urine osteopontin, serum osteopontin, their fragments, and combinations thereof.Type: ApplicationFiled: May 24, 2013Publication date: September 26, 2013Inventors: Wei-Ya Lin, Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ping-Fu Cheng, Tsai-Wei Hsu, Hung-Yi Li, Yi-Ting Chen, Yuh-Feng Ling, Jin-Shuen Chen, Yen-Peng Li
-
Patent number: 8476077Abstract: Disclosed is use of urine and serum biomarkers in diagnosing diabetic nephropathy, staging diabetic nephropathy, monitoring diabetic nephropathy progress, and assessing efficacy of diabetic nephropathy treatments. These biomarkers include urine precursor alpha-2-HS-glycoprotein, urine alpha-1 antitrypsin, urine alpha-1 acid glycoprotein, urine osteopontin, serum osteopontin, their fragments, and combinations thereof.Type: GrantFiled: December 15, 2010Date of Patent: July 2, 2013Assignee: Industrial Technology Research InstituteInventors: Wei-Ya Lin, Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ping-Fu Cheng, Tsai-Wei Hsu, Hung-Yi Li, Yi-Ting Chen, Yuh-Feng Ling, Jin-Shuen Chen, Yen-Peng Li
-
Patent number: 8470547Abstract: Use of urine biomarkers for diagnosing nephropathy, monitoring nephropathy progress, and assessing efficacy of a nephropathy treatment. These urine biomarkers include leukocyte-associated Ig-like receptor-2, alpha-1 acid glycoprotein, their fragments, and combinations thereof.Type: GrantFiled: December 16, 2010Date of Patent: June 25, 2013Assignee: Industrial Technology Research InstituteInventors: Tzu-Ling Tseng, Ching-Fang Lu, Wei-Ya Lin, Tsai-Wei Hsu, Mary Ya-Ping Yeh, Yi-Ting Chen, Chwei-Shiun Yang
-
Patent number: 8465980Abstract: Disclosed is use of urine and serum biomarkers in diagnosing diabetic nephropathy, staging diabetic nephropathy, monitoring diabetic nephropathy progress, and assessing efficacy of diabetic nephropathy treatments. These biomarkers include urine precursor alpha-2-HS-glycoprotein, urine alpha-1 antitrypsin, urine alpha-1 acid glycoprotein, urine osteopontin, serum osteopontin, their fragments, and combinations thereof.Type: GrantFiled: January 27, 2010Date of Patent: June 18, 2013Assignee: Industrial Technology Research InstituteInventors: Wei-Ya Lin, Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ping-Fu Cheng, Tsai-Wei Hsu, Hung-Yi Li, Yi-Ting Chen, Yuh-Feng Ling, Jin-Shuen Chen, Yen-Peng Li
-
Publication number: 20110086372Abstract: Use of urine biomarkers for diagnosing nephropathy, monitoring nephropathy progress, and assessing efficacy of a nephropathy treatment. These urine biomarkers include leukocyte-associated Ig-like receptor-2, alpha-1 acid glycoprotein, their fragments, and combinations thereof.Type: ApplicationFiled: December 20, 2010Publication date: April 14, 2011Applicant: Industrial Technology Research Institute(ITRI)Inventors: Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ching-Fang Lu, Wei-Ya Lin, Tsai-Wei Hsu, Yi-Ting Chen, Chwei-Shiun Yang
-
Publication number: 20110086371Abstract: Use of urine and serum biomarkers in diagnosing diabetic nephropathy, staging diabetic nephropathy, monitoring diabetic nephropathy progress, and assessing efficacy of diabetic nephropathy treatments. These biomarkers include urine precursor alpha-2-HS-glycoprotein, urine alpha-1 antitrypsin, urine alpha-1 acid glycoprotein, urine osteopontin, serum osteopontin, their fragments, and combinations thereof.Type: ApplicationFiled: December 20, 2010Publication date: April 14, 2011Applicant: Industrial Technology Research Institute(ITRI)Inventors: Wei-Ya Lin, Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ping-Fu Cheng, Tsai-Wei Hsu, Hung-Yi Li, Yi-Ting Chen, Yuh-Feng Ling, Jin-Shuen Chen, Yen-Peng Li
-
Publication number: 20110079077Abstract: Use of urine and serum biomarkers in diagnosing diabetic nephropathy, staging diabetic nephropathy, monitoring diabetic nephropathy progress, and assessing efficacy of diabetic nephropathy treatments. These biomarkers include urine precursor alpha-2-HS-glycoprotein, urine alpha-1 antitrypsin, urine alpha-1 acid glycoprotein, urine osteopontin, serum osteopontin, their fragments, and combinations thereof.Type: ApplicationFiled: December 15, 2010Publication date: April 7, 2011Applicant: Industrial Technology Research Institute(ITRI)Inventors: Wei-Ya Lin, Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ping-Fu Cheng, Tsai-Wei Hsu, Hung-Yi Li, Yi-Ting Chen, Yuh-Feng Ling, Jin-Shuen Chen, Yen-Peng Li
-
Publication number: 20110081668Abstract: Use of urine biomarkers for diagnosing nephropathy, monitoring nephropathy progress, and assessing efficacy of a nephropathy treatment. These urine biomarkers include leukocyte-associated Ig-like receptor-2, alpha-1 acid glycoprotein, their fragments, and combinations thereof.Type: ApplicationFiled: December 16, 2010Publication date: April 7, 2011Applicant: INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE(ITRI)Inventors: MARY YA-PING YEH, TZU-LING TSENG, CHING-FANG LU, WEI-YA LIN, TSAI-WEI HSU, YI-TING CHEN, CHWEI-SHIUN YANG
-
Publication number: 20110081667Abstract: Use of urine biomarkers for diagnosing nephropathy, monitoring nephropathy progress, and assessing efficacy of a nephropathy treatment. These urine biomarkers include leukocyte-associated Ig-like receptor-2, alpha-1 acid glycoprotein, their fragments, and combinations thereof.Type: ApplicationFiled: December 15, 2010Publication date: April 7, 2011Applicant: Industrial Technology Research Institute(ITRI)Inventors: Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ching-Fang Lu, Wei-Ya Lin, Tsai-Wei Hsu, Yi-Ting Chen, Chwei-Shiun Yang
-
Publication number: 20100209948Abstract: Use of urine biomarkers for diagnosing nephropathy, monitoring nephropathy progress, and assessing efficacy of a nephropathy treatment. These urine biomarkers include leukocyte-associated Ig-like receptor-2, alpha-1 acid glycoprotein, their fragments, and combinations thereof.Type: ApplicationFiled: January 27, 2010Publication date: August 19, 2010Applicant: Industrial Technology Research Institute(ITRI)Inventors: Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ching-Fang Lu, Wei-Ya Lin, Tsai-Wei Hsu, Yi-Ting Chen, Chwei-Shiun Yang
-
Publication number: 20100197033Abstract: Use of urine and serum biomarkers in diagnosing diabetic nephropathy, staging diabetic nephropathy, monitoring diabetic nephropathy progress, and assessing efficacy of diabetic nephropathy treatments. These biomarkers include urine precursor alpha-2-HS-glycoprotein, urine alpha-1 antitrypsin, urine alpha-1 acid glycoprotein, urine osteopontin, serum osteopontin, their fragments, and combinations thereof.Type: ApplicationFiled: January 27, 2010Publication date: August 5, 2010Applicant: Industrial Technology Research Institute (ITRI)Inventors: Wei-Ya Lin, Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ping-Fu Cheng, Tsai-Wei Hsu, Hung-Yi Li, Yi-Ting Chen, Yuh-Feng Ling, Jin-Shuen Chen, Yen-Peng Li